Ledger.Open graph →
SEC Form D · filed March 24, 2025

Octave Bioscience Inc

Offering
$53.7M
Sold
$31.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

William Hagstrom · MENLO PARK, CADirectorMichael Pellini · MENLO PARK, CADirectorBrook Byers · MENLO PARK, CADirectorA. Grant Heidrich Iii · MENLO PARK, CADirectorThomas Hawes · MENLO PARK, CADirectorGeorge Scangos · MENLO PARK, CADirectorKenton C. Leo · Lone Tree, CODirectorJonathan Landsverk · Greenville, SCDirectorDerrin J. Hill · Provo, UTDirectorClifford Pollard · Oakdale, CADirectorAngela J. Brau · Provo, UTDirectorDana Emberton · Greenville, SCDirectorMarcel Konrad · MENLO PARK, CAExecDoug Biehn · MENLO PARK, CAExec · DirectorLucy Coassin · MENLO PARK, CADirectorBobby Marhamat · San Francisco, CADirectorTuan Ho · San Francisco, CADirectorLeo Polovets · San Francisco, CADirectorChad Byers · San Francisco, CADirectorDaniel Gwak · San Diego, CADirectorPeter Levine · San Diego, CADirectorDoug Biehn · MENLO PARK, CAExec · DirectorLucy Coassin · MENLO PARK, CADirectorMarcel Konrad · MENLO PARK, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗